• U.S. Pharmaceutical Giant Says COVID Vaccine Could Be Ready for Emergency Use by Early 2021

    U.S. pharmaceutical giant Johnson & Johnson says human testing of its experimental coronavirus vaccine will begin by September and says the vaccine could be available for emergency use by early next year.  

    The company said Monday that it has jointly committed more than $1 billion to develop and test a vaccine along with the U.S. Department of Health and Human Services. It said if human trials of the vaccine are successful, it is prepared to produce more than 1 billion doses of the vaccine. 

  • Social Media and Vaccine Misinformation

    People who rely on social media for information were more likely to be misinformed about vaccines than those who rely on traditional media, according to a new study of vaccine knowledge and media use. The researchers found that up to 20 percent of respondents were at least somewhat misinformed about vaccines. Such a high level of misinformation is “worrying” because misinformation undermines vaccination rates, and high vaccination rates are required to maintain community immunity, the researchers said.

  • Antibiotic-Resistant E coli Found in U.S. Veterinary Hospital

    Animals treated in Philadelphia veterinary hospital were found to be infected with a antibiotic-resistant strain of E coli. In the United States, the gene has been detected in only a few human bacterial infections, and never in companion animals. Only a handful of cases in dogs have been reported worldwide.

  • Scary Fact: Vaccination Rates are Falling in Some States

    When Peter J. Hotez moved from Boston to Texas to become the Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, he was surprised to discover the how many children in Texas and other Western states are not vaccinated owing to various exemptions. “In the past year, Europe has been inundated with measles, including dozens of deaths, due to large declines in vaccine coverage. I’m concerned the U.S. could suffer a similar fate,” he writes.

  • New Technique to Transform Anti-Venom Production

    Snake bites kill more than 120,000 people a year, more than a third of them in India. About 400,000 lose limbs after amputations become necessary to prevent the spread of the venom. The number of people bitten by snakes is increasing as a result of more people living near areas which are snake habitats, but the production of venom antidotes has not changed much since anti-venom was first produced in 1896. Scientists are ready to transform the production of anti-venom after mapping the DNA of the Indian cobra for the first time.

  • Tackling the Problem of Antimicrobial Resistance

    The CDC recently announced in its latest report that each year 2.8 million Americans are infected with a drug-resistant organism, and that 35,000 of them would later die. The antimicrobial resistance (AMR) is not new, though, and the problem has been growing for decades, but now it seems that we’re starting to truly take it seriously.

  • California's Stricter Vaccine Exemption Policy Improves Vaccination Rates

    California’s elimination, in 2016, of non-medical vaccine exemptions from school entry requirements was associated with an estimated increase in vaccination coverage at state and county levels, according to a new study.

  • We Must Talk More about Measles — and Less about Anti-Vaxxers

    There are two basic stories we hear when talking about measles: first, that the disease has more or less been eradicated, and second, that it has resurfaced — more than 440,000 cases were reported worldwide between January and November — because of mindless anti-vaxxers who ignore science, mistrust experts, and who spfread misinformation from the comfort of their Internet echo chambers. “Both of these narratives, however, are, at best, partial truths,” Laurence Monnais writes.

  • Disease Outbreaks Are on the Rise, So Legislators Are Taking Action

    Vaccine-preventable disease (VPD) outbreaks are increasing in frequency in the United States, but this trend is also met with an uptick in legislation aimed at increasing childhood vaccination in places where those epidemics occurred, according to a new study.

  • Firehosing: The Systemic Strategy that Anti-Vaxxers Are Using to Spread Misinformation

    “Firehosing” relies on pushing out as many lies as possible as frequently as possible. Firehosing is effective because its goal isn’t to persuade. It’s to rob facts of their power. “The strategy is effective for those trying to hold on to political power, and it’s the same for those who gain power from engaging in science denial,” Lucky Tran writes.

  • New Smallpox Vaccine Tested by USAMRIID Receives FDA Approval

    Army scientists played a key role in testing a new smallpox vaccine approved last week by the U.S. Food and Drug Administration. Marketed under the brand name JYNNEOS, the product, developed by Bavarian Nordic, is a live, non-replicating vaccine for the prevention of both smallpox and monkeypox disease in adults.

  • Engineered Viruses Could Fight Antibiotic Resistance

    Antibiotic resistance is a one of the world’s most pressing public health problems. Scientists working on an Army project have developed a new weapon to combat super-bugs, which could protect Soldiers and fight resistance.

  • Why There’s Still No Lyme Vaccine for Humans

    There is no vaccine for Lyme disease, and Valneva, a French biotech company focused on developing vaccines for infectious diseases, hopes to change that. Valneva’s Lyme vaccine isn’t the first designed for people. Twenty years ago, Reeder could have been immunized. From 1999 to 2002, SmithKline Beecham—now GlaxoSmithKline—sold a Lyme vaccine called LYMErix. But the company pulled LYMErix off the market after a public backlash and a spate of lawsuits. If the new vaccine does make it to market, will it fare any better than LYMErix?

  • Declaring Vaccine Hesitancy One of the Ten Biggest Health Threats in 2019 Is Unhelpful

    The rhetoric is well-known: vaccines work, the science is settled, vaccine-hesitant parents are uninformed or misguided victims of the social media platforms where crooks spread fake science. It is taken as a given that vaccines are similarly and uniformly beneficial – aside from rare side effects – and no sane person would question that. But are vaccines similarly and uniformly beneficial? There is no doubt that vaccines can induce immunological “memory” against their target disease. And, at the population level, this reduces the risk of getting the target disease. Vaccine led to the eradication of smallpox, and we are close to eradicating two other serious infections: polio and measles. But we don’t have a lot of evidence about the overall health effects of vaccines. Everybody has been so sure that vaccines only protected against the target infection, nothing else, and so nobody studied the overall health effects. They were simply assumed to be proportionally beneficial. We do not have the evidence for all vaccines to tell vaccine-hesitant parents that it is overall beneficial for their child to receive each one of them. Rather, we have to acknowledge that there are things about vaccines that have not been investigated very well.

  • U.S. Measles Cases Hit 1,234 as Brooklyn Outbreak Called Over

    The other day the Centers for Disease Control and Prevention (CDC) confirmed 19 new measles infections, raising the 2019 total to 1,234 cases in 31 states. One additional state has been affected since the CDC’s last update, but the number of active outbreaks has been reduced to four, down from six noted last week.